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he Heart of a Champion*
aul S. Bhella, MD, Benjamin D. Levine, MD
allas, Texas
lite endurance athletes are the paragons of circulatory
ealth—able to generate extremely high rates of oxygen
ptake by virtue of “Olympic sized” oxygen transport
ystems. The primary cardiovascular adaptation of an en-
urance athlete that allows for such extraordinary aerobic
ower is a very large stroke volume (1) achieved by a large,
ompliant heart (2) that relaxes quickly (3). Although these
hanges facilitate an augmentation of cardiac output in
esponse to increased metabolic demand, some have ques-
ioned whether they might be accompanied by yet unrec-
gnized, long-term risks. Indeed, the term “the athlete’s
eart” was originally coined to suggest pathological cardiac
nlargement as perceived by early clinical investigators (4).
upporting this notion are the well-described phenomena of
cardiac fatigue” (5), post-exercise elevations in cardiac
pecific biomarkers (6), and long-term changes in cardiac
orphology that might mirror those observed in pathologic
onditions. In this issue of the Journal, Pelliccia et al. (7),
ho have contributed much to this field, further explore this
isk/benefit relationship by reporting the results of a longi-
udinal cardiovascular evaluation in 114 highly successful
nd intensively trained Olympic endurance athletes.
See page 1619
“Cardiac fatigue,” a phrase coined to describe transient
hanges in left ventricular performance after extraordinary
ndurance events, has been observed by several investigators
fter a variety of athletic endeavors. Douglas et al. (5)
rought these observations to the mainstream in the late
980s in their study of 21 athletes at the Hawaii Ironman
riathlon, an event lasting approximately 8 to 9 h for the
astest runners. With echocardiography before and after the
ace and after a period of recovery, the authors observed a
eduction in fractional shortening by 10% from pre-race to
ost-race studies, only to have this index return to pre-race
evels in the recovery period (5), a finding that has been
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Institute for Exercise and Environmental Medicine, Texas Healthi
resbyterian Dallas, and the Division of Cardiology, University of Texas Southwest-
rn Medical Center, Dallas, Texas.onfirmed by these and other investigators (8). Elevations in
ardiac-specific biomarkers, such as troponin I and T, have
lso been noted after endurance events; although in contrast
o the cardiac fatigue studies, these elevations seem to be
reatest in the least trained and slowest runners (9). Used
redominantly in the diagnosis of acute coronary syn-
romes, these biomarkers are highly sensitive for myocardial
njury (or at least changes in membrane permeability), with
levations also noted in myocarditis, pulmonary embolism,
nd heart failure. In a recent meta-analysis by Shave et al.
6), pooling 1,120 endurance athletes, post-exercise tropo-
in T exceeded the lower limit of detection (0.01 g/l) in
ust under one-half of the participants, revealing the high
revalence of mild elevations of troponin in this population.
inally, the typical description of the athlete’s heart, one
hich features an enlarged left ventricular chamber with
hickened walls and a resting ejection fraction at the lower
imits of normal, often mirrors some changes observed in
athological conditions such as hypertrophic or dilated
ardiomyopathies. Hence, although specific parameters for
ifferentiating the athlete’s heart from pathophysiologic
esponses to cardiovascular disease have been defined (10)
nd prove helpful in the majority of cases, some fraction of
thletic hearts will exceed these cutoffs, especially in large
ale athletes like the rowers and canoeists studied in this
aper. Whether the cardiac phenotype of these athletes
epresents an extreme form of benign remodeling or rather
eflects pre-clinical pathology is a matter of some
ncertainty.
Although the mechanisms that underlie these divergent
bservations are poorly understood, the question of whether
epetitive episodes of subtle injury might lead to long-term
hanges in left ventricular morphology and function is
ermane. Recurrent subtle injury might lead to alterations of
ystolic or diastolic function, as has been suggested in
yclists who have competed in multiple Tour de France
aces (11) or older marathon runners competing in multiple
arathons (12).
To address this question, Pelliccia et al. (7) used physical
xaminations, electrocardiograms, and echocardiograms
erformed by the Italian National Olympic Committee and
eported the results of serial examinations of endurance
thletes who competed in a minimum of 2 Olympics games,
ith a mean follow-up of 9 years. Key findings included:
) the absence of clinical events including syncope, cardiac
rrest, or sudden cardiac death; 2) the absence of progressive
hanges in left ventricular morphology, including end-
iastolic volume, end-systolic volume, and wall thickness;
nd 3) the absence of changes in contractile function, as
ssessed by ejection fraction and the ratio of peak systolic
ressure to end systolic volume (PSP/ESV).
The work of Pelliccia et al. (7) is to be commended,
ecause it offers objective evidence that prolonged and
ecurring Olympic level training requiring high volume and
ntensity of training as well as repetitive competitions does
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April 13, 2010:1626–8 The Heart of a Championittle to alter cardiac phenotype or performance. The addi-
ion of a control group with persistent training but failure to
ualify for a second Olympic Games is a further strength
nd gives confidence that the results are not exclusively due
o selection bias where only the athletes with preserved
unction were able to remain successful at this level. More-
ver, these Olympic athletes were carefully monitored and
creened for doping, a problem that has plagued competitors
n the Tour de France and that might have confounded
revious research in this area (11). Lastly, as noted by the
uthors, virtually all studied athletes were Italians and
aucasian; athletes of African origin might have measure-
ble differences in cardiac morphology (13). Nonetheless,
he high internal validity of this population makes up for
ny limitation in external validity, although additional
tudies in non-Caucasian athletes are warranted.
In contrast to the study’s numerous strengths, a few
imitations should also be considered. Most evident is that
ubtle changes in left ventricular systolic or diastolic func-
ion might escape detection of crude measures of systolic
erformance such as the ejection fraction. Although a
ornerstone of clinical echocardiography, this index is ex-
uisitely load-dependent and prone to high test-retest
ariability. Fortunately, the addition of an ejection phase
ndex normalized to afterload, such as the peak systolic
ressure/end-systolic volume provides additional confidence
hat systolic function remained normal in this population.
oreover, in the authors’ defense, all echocardiographic
tudies were performed before 2005; since then, more
ensitive techniques have become available, including myo-
ardial tissue Doppler, strain analysis, and strain rate anal-
sis. Subtle changes in cardiac function over shorter periods
f time might require more sophisticated, sensitive tech-
iques such as these.
The development of myocardial fibrosis and consequent
isk of arrhythmias is a final topic of concern for the athlete’s
eart. Whether years of training and competition might
ead to a fibrotic heart prone to arrhythmia is arguable (12),
lthough until now there were virtually no longitudinal
tudies examining this issue. Such is the scenario posed in a
ase report by Whyte et al. (14), who detail the case of a
7-year-old competitive marathoner who died while run-
ing; postmortem evaluation revealed a hypertrophic and
brotic heart, leading the authors to speculate these findings
ere secondary to years of extensive training and competi-
ion. The presence of delayed enhancement of gadolinium
n cardiac magnetic resonance imaging (cMRI) in approx-
mately 5% of older marathon runners in a nonischemic
attern is supportive of this hypothesis (12), although this
requency was not clearly distinguishable from that observed
n a control population of similar age (50 to 72 years).
oreover, it is impossible to separate the effects of mara-
hon running itself from the effects of other clinical consid-
rations, such as intensive exercise training in the presence
f subclinical coronary heart disease in such patients. In
ight of these concerns, the absence of syncope, cardiacrrest, or sudden cardiac death in the Italian cohort is
ertainly reassuring, as is the lack of change in cardiac
orphology. It should be noted, however, that 2 of these
14 athletes did indeed have significant ventricular arrhyth-
ias that required medical intervention, so this issue cannot
e completely ignored, especially given a preliminary, un-
ublished report that suggests that even some younger
thletes might have increased delayed enhancement on
MRI (15).
The data now reported by Pellicia et al. (7) in young elite
ompetitive athletes in a longitudinal fashion are scientifi-
ally more rigorous to answer the question at hand—does
rolonged, intensive exercise by itself injure the heart?
hether another 20 years of marathon-style training is
ufficient to cause myocardial injury is possible, although it
s not clear why that should be the case, given the remark-
ble stability of cardiovascular structure and function over
early 1 decade of elite training and competition. Moreover,
t is reassuring that recent studies show no evidence of
ncreased delayed enhancement in the myocardium after a
arathon, despite elevations in plasma biomarkers (16). It
ust be acknowledged, however, that the presence of
rrhythmogenic foci and subclinical episodes of arrhythmia
ere not thoroughly assessed in the work by Pellicia et al.
7). Use of advanced tools such as cMRI might be necessary
o apply on a systematic basis, longitudinally in both young
nd older athletes, to convincingly disprove this hypothesis.
The athlete’s heart remains as much a mystery as a
arvel. Whether observations such as cardiac fatigue, ele-
ated biomarkers, and pronounced morphologic and func-
ional changes represent benign physiologic adaptations or
ross into the category of pathology remains uncertain.
owever, the report by Pellicia et al. (7) goes a long way to
eassure the medical community of the inherently physio-
ogic and clinically benign nature of prolonged and intense
ndurance training.
eprint requests and correspondence: Dr. Benjamin D. Le-
ine, Institute for Exercise and Environmental Medicine, 7232
reenville Avenue, Suite 435, Dallas, Texas 75231. E-mail:
enjaminLevineMD@texashealth.org.
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